Wakefit’s Q2 revenue hits ₹452 Cr but profit stagnates as raw material costs and geopoliti

The results, reported by *Inc42*, underscore the challenges facing India’s fastest-growing mattress brand, where soaring raw material costs, macroeconomic pressures, and a "challenging" operating environment are eating into margins despite strong top-line growth.

The stagnant profit came despite a sequential 11.6% revenue increase to ₹452 crore, driven by a 20% year-over-year jump. Yet total expenses rose 19% to ₹441.4 crore, while additional tax charges—including a ₹6.4 crore deferred tax hit—further pressured the bottom line. Wakefit’s operating EBITDA margin improved slightly to 6.7% from 6.4% year-over-year, but the sequential profit decline signals deeper operational strains.

The core issue stems from the company’s reliance on commodity-linked inputs. Mattresses account for 66% of revenue, and the sector’s two most critical raw materials—both tied to crude prices—have seen sustained price increases. The broader supply chain has also faced disruptions, particularly in logistics and availability. The timing couldn’t be worse: Wakefit’s planned ₹100 crore to ₹120 crore capex for FY27, 80% of which is earmarked for retail expansion, hinges on maintaining operational efficiency.

Wakefit’s aggressive growth strategy is visible in its store count. The company opened 41 new offline outlets in Q2 FY27, bringing its company-owned store tally to 205 across 137 cities. Multi-brand partnerships now span 2,589 outlets in 787 towns, with proprietary channels contributing 70% of sales. But the push into larger "jumbo store" formats—construction of the first in Bengaluru is underway for a Q2 FY28 launch—will require even greater capital discipline. The company’s supply chain is already strained, with a 1.6 lakh sq. ft. mother warehouse in Hosur and 10 inventory holding points barely keeping pace with demand.

The contrast with other Indian consumer brands turning profitable this year—like *ixigo* (₹63 crore Q2 profit), *MobiKwik* (₹11.83 crore), and *Delhivery* (posting a net profit after years of losses)—highlights Wakefit’s unique vulnerability. Unlike logistics or fintech, where margins can scale with volume, mattress manufacturing is heavily tied to commodity cycles. Wakefit’s ability to pass on price increases to consumers without alienating its value-conscious customer base will determine whether its revenue growth translates into sustainable profitability.

Shares on the BSE closed 1.1% lower at ₹138.75, reflecting investor caution. The question now is whether Wakefit can outpace inflation in its supply chain—or whether the company’s expansion will remain hostage to macroeconomic and geopolitical risks. For now, the results suggest the latter is winning.

Sources: inc42.com